The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Abstract
Acinetobacter species and Pseudomonas aeruginosa are noted for their intrinsic resistance to antibiotics and for their ability to acquire genes encoding resistance determinants. Foremost among the mechanisms of resistance in both of these pathogens is the production of beta -lactamases and aminoglycoside-modifying enzymes. Additionally, diminished expression of outer membrane proteins, mutations in topoisomerases, and up-regulation of efflux pumps play an important part in antibiotic resistance. Unfortunately, the accumulation of multiple mechanisms of resistance leads to the development of multiply resistant or even "panresistant" strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.891-897.2000 · Cited by 562
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 425
Marchand, I., Damier-Piolle, L., Courvalin, P., & Lambert, T. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3298-3304.2004 · Cited by 407
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Self-citationToleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 327
Livermore, D. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.2046 · Cited by 288
Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K., Kato, N., & Ohta, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.349 · Cited by 275
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Naas, T., & Nordmann, P. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112185101 · Cited by 250
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
Navon-Venezia, S., Ben-Ami, R., & Carmeli, Y. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000171920.44809.f0 · Cited by 242
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Miller, G. H., Sabatelli, F. J., Hare, R. S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K. J., & Groups, A. R. S. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s46 · Cited by 235
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Donald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Nemec, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45716-0 · Cited by 226
Philippon, L. N., Naas, T., Bouthors, A. T., Barakett, V, & Nordmann, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2188 · Cited by 215
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods
Livermore, D. M. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02013107 · Cited by 210
Cometta, A., Baumgartner, J. D., Lew, D., Zimmerli, W., Pittet, D., Chopart, P., Schaad, U., Herter, C., Eggimann, P., & Huber, O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1309 · Cited by 202
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa
Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y., & Labia, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.962 · Cited by 201
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Naas, T., & Nordmann, P. (1999) · PubMed · Cited by 183
Gibb, A. P., Tribuddharat, C., Moore, R. A., Louie, T. J., Krulicki, W., Livermore, D. M., Palepou, M.-F. I., & Woodford, N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.255-258.2002 · Cited by 169
Yum, J. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf043 · Cited by 163
Jaccard, C., Troillet, N., Harbarth, S., Zanetti, G., Aymon, D., Schneider, R., Chiolero, R., Ricou, B., Romand, J., Huber, O., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2966 · Cited by 160
Poirel, L., Karim, A., Mercat, A., Thomas, I., Vahaboğlu, H., Richard, C., & Nordmann, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.157 · Cited by 156
Molecular Characterization of an Epidemic Clone of Panantibiotic-ResistantPseudomonas aeruginosa
Deplano, A., Denis, O., Poirel, L., Hocquet, D., Nonhoff, C., Byl, B., Nordmann, P., Vincent, J., & Struelens, M. J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1198-1204.2005 · Cited by 146
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa
Higgins, P. G. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00009-8 · Cited by 138
Nordmann, P., & Naas, T. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.104 · Cited by 134
An SHV-Derived Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa
Naas, T., Philippon, L., Poirel, L., Ronco, E., & Nordmann, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1281 · Cited by 129
Poirel, L., Girlich, D., Naas, T., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.447-453.2001 · Cited by 129
Lolans, K., Queenan, A. M., Bush, K., Sahud, A., & Quinn, J. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3538-3540.2005 · Cited by 126
Aubert, D., Poirel, L., Chevalier, J., Léotard, S., Pagès, J., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1615-1620.2001 · Cited by 115
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Five novel plasmid-determined beta-lactamases
Medeiros, A. A., Cohenford, M. A., & Jacoby, G. A. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.715 · Cited by 91
Danel, F., Hall, L. M., Gür, D., & Livermore, D. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.785 · Cited by 90
Luzzaro, F., Mantengoli, E., Perilli, M., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.5.1865-1870.2001 · Cited by 84
Brown, S., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01096.x · Cited by 78
Oh, E., Lee, S., Park, Y.-J., et al. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(03)00090-3 · Cited by 76
Lister, P., Gardner, V. M., & Sanders, C. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.882 · Cited by 70
Boissinot, M., & Lévesque, R. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40181-6 · Cited by 60
VEB-1-like Extended-Spectrum ß-Lactamases inPseudomonas aeruginosa, Kuwait
Poirel, L., Rotimi, V. O., Mokaddas, E. M., Karim, A., & Nordmann, P. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010322 · Cited by 57
Sequence of the PSE-1 β-Lactamase Gene
Huovinen, P., & Jacoby, G. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2428 · Cited by 48
Endimiani, A., Luzzaro, F., Pini, B., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-52 · Cited by 46
Naas, T., Poirel, L., & Nordmann, P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00202-x · Cited by 40
Lachapelle, J., Dufresne, J., & Lévesque, R. C. (1991) · Gene · doi:10.1016/0378-1119(91)90530-o · Cited by 35
Carricajo, A., Vermesch, R., & Auhert, G. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00238.x · Cited by 14
Cited by
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Lee, J., & Zhang, L. (2015) · Protein & Cell · doi:10.1007/s13238-014-0100-x · Cited by 1,346
Metadata
- Authors
- Bonomo, R. A., & Szabo, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-01
- Volume
- 43
- Issue
- Supplement_2
- Pages
- S49-S56
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2153969539
- Cited by
- 741
- References
- 59
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.